Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
B

Challenging Case of a 55 y/o With Mantle Cell Lymphoma: TP53 Mutations Pose a Considerable Challenge to Conventional Therapy

By Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies FEATURING Bijal Shah
By Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies FEATURING Bijal Shah
314 views
January 27, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
16:05
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: What Is High Risk MCL and How Should We Treat It

Feat. A. Kumar
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
05:24
Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…

05:28
GRACE

3L Treatment for Mantle Cell Lymphoma

Feat. T. Phillips
12:54
The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…

Feat. M. Narkhede
06:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …

Feat. N. Shah
44:19
University of Colorado Division of Hematology

Mantle Cell Lymphoma: Challenges & Prospects

Feat. J. Jasem
04:13
GRACE

The TRIANGLE Study: Ibrutinib Maintenance for MCL

Feat. T. Phillips
07:47
PrecisCa

Treatment Approach for Older Patients With Mantle Cell Lymphoma: A D…

Feat. M. Kamdar
14:51
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Is Stem Cell Transplantation Still Necessary in Frontline…

Feat. T. Fenske
08:19
ASH 2022 Conference Coverage

ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…

Feat. N. Shah
03:26
PrecisCa

The BRUIN Study: Pirtobrutinib in Mantle Cell Lymphoma

Feat. M. Kamdar